Jordan joined InfanDx as Vice President, US Operations in April 2022 with 11 years of experience working in the IVD sector. He joined InfanDx from Everly Health Solutions, where he led their Life Sciences and Research business unit. Prior to Everly Health, Jordan worked as a Director of Business Development at Beaufort CRO, a diagnostics focused contract research organization. Jordan started his career at Epigenomics where he worked in a variety of escalating clinical research and business development capacities, helping to gain approval for, and commercialize, the first FDA-approved liquid biopsy cancer screening test.